These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6252028)

  • 1. Effect of the time interval between blood sampling and assay on serum angiotensin I-converting enzyme activity from captopril-treated rats.
    Lai FM; Tanikella T; Herzlinger H; Cervoni P
    Eur J Pharmacol; 1980 Oct; 67(1):97-9. PubMed ID: 6252028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissociation of the effect of captopril on blood pressure and angiotensin converting enzyme in serum and lungs of spontaneously hypertensive rats.
    Forslund T; Tikkanen I; Grönhagen-Riska C; Fyhrquist F
    Acta Pharmacol Toxicol (Copenh); 1981 Nov; 49(5):416-21. PubMed ID: 6285670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin-I converting enzyme activity in the sera of captopril-treated hypertensive patients.
    Rosenthal T; Holtzman E; Yaron A
    Clin Exp Hypertens A; 1982; 4(3):367-77. PubMed ID: 6280902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The measurement of angiotensin-converting enzyme in subjects receiving captopril.
    Roulston JE; MacGregor GA
    N Engl J Med; 1980 Aug; 303(7):397. PubMed ID: 6248782
    [No Abstract]   [Full Text] [Related]  

  • 5. Responses of blood pressure and angiotensin-converting enzyme activity to acute captopril administration in normotensive and hypertensive rats.
    Levens NR; Peach MJ; Vaughan ED; Weed WC; Carey RM
    Endocrinology; 1981 Feb; 108(2):536-44. PubMed ID: 6256155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of cadmium and captopril on serum angiotensin converting enzyme activity in rats.
    Puri VN
    Indian Heart J; 1997; 49(3):297-9. PubMed ID: 9291654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decrease of serum angiotensin converting enzyme activity after discontinuation of captopril treatment.
    Forslund T; Tikkanen I; Fyhrquist F
    Acta Pharmacol Toxicol (Copenh); 1983 Jul; 53(1):78-80. PubMed ID: 6310960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of angiotensin I-converting enzyme rat lung with Captopril (SQ 14225).
    Fyhrquist F; Forslund T; Tikkanen I; Grönhagen-Riska C
    Eur J Pharmacol; 1980 Oct; 67(4):473-5. PubMed ID: 6256177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Competitive inhibitor binding assay (IBA) of captopril and other inhibitors of angiotensin converting enzyme.
    Tikkanen FF; Grönhagen-Riska C
    Scand J Urol Nephrol Suppl; 1984; 79():13-6. PubMed ID: 6089313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of angiotensin I-converting enzyme in rat lung with captopril: the effect of adrenalectomy.
    Fyhrquist F; Grönhagen-Riska C; Forslund T; Tikkanen I
    Am J Cardiol; 1982 Apr; 49(6):1508-10. PubMed ID: 6280480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between lung and plasma angiotensin converting enzyme and the hypotensive effect of captopril in conscious rabbits.
    Chen X; Pitt BR; Moalli R; Gillis CN
    J Pharmacol Exp Ther; 1984 Jun; 229(3):649-53. PubMed ID: 6327968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma-converting enzyme activity does not reflect effectiveness of oral treatment with captopril.
    Unger T; Schüll B; Hübner D; Yukimura T; Lang RE; Rascher W; Ganten D
    Eur J Pharmacol; 1981 Jun; 72(2-3):255-9. PubMed ID: 6265248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opposite effects of captopril on angiotensin I-converting enzyme 'activity' and 'concentration'; relation between enzyme inhibition and long-term blood pressure response.
    Boomsma F; de Bruyn JH; Derkx FH; Schalekamp MA
    Clin Sci (Lond); 1981 May; 60(5):491-8. PubMed ID: 6265138
    [No Abstract]   [Full Text] [Related]  

  • 14. Assay of plasma angiotensin-converting enzyme activity in captopril-treated subjects.
    Lijnen P; Staessen J; Amery A
    Methods Find Exp Clin Pharmacol; 1982; 4(6):413-5. PubMed ID: 6292595
    [No Abstract]   [Full Text] [Related]  

  • 15. ACE activity during the hypotension produced by standardized aqueous extract of Cecropia glaziovii Sneth: a comparative study to captopril effects in rats.
    Ninahuaman MF; Souccar C; Lapa AJ; Lima-Landman MT
    Phytomedicine; 2007 May; 14(5):321-7. PubMed ID: 17433647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of acute cardiovascular effects of cadmium and captopril in relation to oxidant and angiotensin converting enzyme activity in rats.
    Puri VN; Saha S
    Drug Chem Toxicol; 2003 Aug; 26(3):213-8. PubMed ID: 12953661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of long-term blockade of angiotensin converting enzyme with captopril (SQ14,225) on hemodynamics and circulating blood volume in SHR.
    Koike H; Ito K; Miyamoto M; Nishino H
    Hypertension; 1980; 2(3):299-303. PubMed ID: 6248462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of time and dose on angiotensin converting enzyme during captopril treatment in the rat.
    Forslund T
    Acta Pharmacol Toxicol (Copenh); 1983 Mar; 52(3):201-4. PubMed ID: 6303049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacology of idrapril: a new class of angiotensin converting enzyme inhibitors.
    Subissi A; Criscuoli M; Sardelli G; Guelfi M; Giachetti A
    J Cardiovasc Pharmacol; 1992 Jul; 20(1):139-46. PubMed ID: 1383623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetic studies of the pharmacologic response to captopril in rats. II. Hypotensive effect and plasma angiotensin converting enzyme activity.
    Endoh M; Suzuki M; Katayama K; Kakemi M; Koizumi T
    J Pharmacobiodyn; 1989 Jan; 12(1):10-7. PubMed ID: 2542517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.